Renovaro Cube’s AI platform is purpose-built to process and analyze multi-omic molecular data, facilitating the discovery of biomarkers critical for early cancer detection, monitoring, and treatment ...

Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development ...

Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024. See why I rate ...

Technologies should be designed to serve the greater good, promoting fairness, transparency, and positive impact for the ...

Dr. Doberstein joins a distinguished group of board members with deep expertise in biotechnology, AI-driven drug discovery, and clinical development, further strengthening Invea’s leadership as it ...

Indiana University has landed a $138 million grant from the Lilly Endowment that will fund construction of a state-of-the-art ...

A machine learning model for analysing brain lesion scans after stroke could mean up to 50% more patients receive appropriate ...

Pick the best stocks and maximize your portfolio: Thomas Smith’s rating is based on a series of promising developments in Disc Medicine’s hematology-focused pipeline. During the ASH 2024 ...

Sensor-based imaging data serves as a rich source of information for machine learning ... making process of the deep learning model. The practical application involves taking an input image that the ...

She completed a residency in internal medicine and a ... along with insights from machine learning and AI, Cartography is identifying and developing therapeutics against highly specific targets and ...

"This devastating disease can eliminate the small number of cattle or buffalo that families rely on for their livelihood," says Schryvers, a professor at the Cumming School of Medicine.

Apogee Ther­a­peu­tics, an I&I bi­o­log­ics mak­er that quick­ly went pub­lic in 2023, said Mon­day it’s head­ed to­ward a Dupix­ent face-off next year as it looks … ...